April 30 (SeeNews) - Croatian food and pharmaceuticals manufacturer Podravka Group [ZSE:PODR] said on Tuesday its consolidated net profit after minority interests rose to 23.6 million euro ($25.3 million) in the first quarter of this year from 15.9 million euro in the same period of 2023.
Normalised operating profit before depreciation and amortisation (EBITDA) amounted to 38 million euro and is almost 38% higher on the year, Podravka said in a consolidated unaudited report to the Zagreb bourse.
In the first quarter, the Podravka group recorded revenue of 191.8 million euro, up 9.1%, on the year.
The revenue of its food segment increased 11.3% to 146.5 million euro, while the pharmaceuticals segment generated a revenue of 45.3 million euro, up 2.5% compared to January-March 2023.
Normalized operating expenses totalled 162.1 million euro, up 3.8% on the year.
Shares of the parent company of the group, Podravka d.d., traded 0.64% higher at 158 euro on intraday on Tuesday on the Zagreb bourse.
($ = 0.932 euro)